Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Atea Pharmaceuticals Ownership Summary


Atea Pharmaceuticals is owned by 43.83% institutional investors, 13.61% insiders, and 42.56% retail investors. Fmr is the largest institutional shareholder, holding 14.66% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 8.17% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtea Pharmaceuticals43.83%13.61%42.56%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.95M14.66%$64.30M
Blackrock9.12M10.87%$30.19M
Blackrock funding, inc. /de8.44M10.35%$45.38M
Bml capital management7.06M8.66%$37.98M
Tang capital management4.81M5.91%$25.90M
Vanguard group4.23M5.35%$15.09M
Bain capital life sciences investors2.36M2.90%$12.70M
Two sigma investments, lp1.86M2.29%$10.03M
Geode capital management1.75M2.14%$9.41M
State street1.69M2.08%$9.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management7.06M24.38%$37.98M
Rosalind advisors1.17M2.53%$6.30M
Cm management355.00K1.60%$1.91M
Tang capital management4.81M1.32%$25.90M
Peapod lane capital272.82K1.18%$1.44M
Bain capital life sciences investors2.36M1.15%$12.70M
Aldebaran capital89.95K0.37%$483.91K
Auour investments177.00K0.30%$952.26K
Rangeley capital46.50K0.24%$250.17K
Opaleye management322.60K0.23%$1.74M

Top Buyers

HolderShares% AssetsChange
Fmr11.95M0.00%2.27M
Rosalind advisors1.17M2.53%1.17M
Two sigma investments, lp1.86M0.01%1.12M
Vanguard fiduciary trust484.70K0.00%484.70K
Acadian asset management1.58M0.01%278.91K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---3.34M
Vanguard group4.23M0.00%-482.17K
Almitas capital---445.39K
Bml capital management7.06M24.38%-431.34K
Jpmorgan chase940.16K0.00%-408.14K

New Positions

HolderShares% AssetsChangeValue
Rosalind advisors1.17M2.53%1.17M$6.30M
Vanguard fiduciary trust484.70K0.00%484.70K$2.61M
Arrowstreet capital, limited partnership210.54K0.00%210.54K$1.13M
Sei investments156.38K0.00%156.38K$841.35K
Eam investors112.87K0.07%112.87K$607.22K

Sold Out

HolderChange
Srs capital advisors-8.00
Nelson, van denburg & campbell wealth management group-15.00
Federation des caisses desjardins du quebec-24.00
Capital performance advisors llp-31.00
Colonial trust advisors-46.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202573-37.61%34,651,553-34.79%431.09%24-45.45%29-27.50%
Sep 30, 20251137.62%52,737,5330.09%621.59%41-16.33%4053.85%
Jun 30, 2025104-52,674,2040.85%621.67%4911.36%25-32.43%
Mar 31, 2025104-2.80%52,838,521-6.02%621.40%45-15.09%3822.58%
Dec 31, 2024105-2.78%56,185,130-2.97%661.41%52-1.89%303.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S6.54M8.17%30.70K
Fidelity Growth Compy Commingled Pl O3.73M4.42%23.40K
Fidelity Growth Company Fund3.05M3.82%491.35K
Vanguard Total Stock Mkt Idx Inv2.37M2.97%-
Vanguard US Total Market Shares ETF2.36M2.76%-
iShares Russell 2000 ETF1.66M2.07%13.96K
Fidelity Growth Company K61.23M1.53%1.52K
Vanguard Institutional Extnd Mkt Idx Tr809.01K1.02%62.45K
Fidelity Series Growth Company728.82K0.91%127.54K
Fidelity Small Cap Index692.66K0.87%2.83K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 16, 2025BERGER FRANKLIN M-Buy$33.61K
Jan 15, 2025BERGER FRANKLIN M-Buy$47.88K
Jan 16, 2025BERGER FRANKLIN M-Sell$33.61K
Jan 15, 2025BERGER FRANKLIN M-Sell$47.88K
Dec 10, 2024BERGER FRANKLIN M-Sell$1.02M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q14-
2024 Q4-1
2024 Q3-3

AVIR Ownership FAQ


Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 43.83%, followed by 13.61% insiders and 42.56% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 379.48%, which Atea Pharmaceuticals falls below.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Fmr (11.95M shares, 14.66%), Blackrock (9.12M shares, 10.87%), and Blackrock funding, inc. /de (8.44M shares, 10.35%). Together, they hold 35.88% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 24.38% of its assets in 7.06M Atea Pharmaceuticals shares, valued at 37.98M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 8.17% of its total shares outstanding invested in 6.54M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools